May 6 (Reuters) - Hedge fund Shah Capital said on Monday that it intends to vote against election of three directors on the board of COVID-19 vaccine maker Novavax.

Shah Capital said it currently owns about 7.5% of Novavax's outstanding shares. (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar)